Dermatology Activities
Addressing the Needs of Adolescent Patients With Moderate to Severe Atopic Dermatitis
0290-0000-20-071-H01-P
This activity will explain atopic dermatitis pathophysiology, including the role of interleukins in type 2 inflammation and disease pathology.
1.00
Reviewing Interleukin 17— and Interleukin 23—targeting Therapies and Best Practices in Psoriatic Disease Management Feat. Clinical Practice Video Vignettes
0290-0000-20-043-H01-P
This activity includes patient counseling videos that highlight the vital roles of specialty pharmacists in assisting patients with PsO and PsA via clinical interventions, educating patients about administration, and monitoring patient response and adherence to selected therapy.
2.00
An American Journal of Managed Care® Symposium: Living With Psoriatic Disease
0290-0000-19-240-H01-P
This free activity will highlight important ways to consider the effectiveness and cost-efficacy data along with patients’ preferences and disease severity in ascertaining how to optimize care for patients with PsO and PsA.
1.50
Examining Interleukin-17- and Interleukin-23-Inhibiting Biologics for Psoriasis and Psoriatic Arthritis Treatment
0290-0000-19-232-H01-P
This free activity will examine the pathophysiology of psoriatic disease with emphasis on the interleukin-17 and interleukin-23 pathways
1.00